Bioxytran, Inc. (OTCQB:BIXT), a clinical-stage biotechnology company developing carbohydrate-based therapeutics, today ...

A randomized clinical trial involving 958 older adults suggests that taking a daily multivitamin for two years may produce a small, statistically significant slowdown in two measures of biological ...

The COSMOS trial found that a daily multivitamin delayed biological aging by 2.7 to 5.1 months, and that this effect was more apparent in older adults who are already experiencing accelerated aging.

Correlative Science in the Cooperative Group System: Re-Engineering for Success Clinical trials frequently include multiple end points that mature at different times. The initial report, typically ...

Tirzepatide, which is marketed as Zepbound for chronic weight management, is a dual GIP and GLP-1 receptor agonist that has ...

Virta Health, the leader in reversing metabolic disease, announced today results from a randomized, controlled Phase II clinical trial (RCT), offering an early signal that could reshape how advanced ...

Evidence continues to mount suggesting that GLP-1 drugs like Ozempic and Wegovy may help people cut back on cigarettes, ...

A study published in JAAD has found that high-dose Vitamin D during pregnancy may help prevent atopic dermatitis in children of mothers exposed to tobacco smoke. In a post-hoc analysis of ...

Low dose alnodesertib plus gemcitabine met the primary endpoint of progression-free survival (PFS) versus gemcitabine alone ...

New evidence shows regular aspirin use is associated with a lower incidence of aortic valve calcification and aortic stenosis ...